Concord Drugs Ltd receives orders worth Rs. 14.71 crores

Concord Drugs Limited has received significant purchase orders from various entities for supply of our products during the period of December, 2025.

The aggregate value of these orders is approximately Rs. 14,70,52,192.59 (approximately Rs. 14.71 Crores), which exceeds the materiality threshold prescribed under the Company's Policy on Determination of Materiality of Events, and is expected to have a positive impact on the business and operations of the Company.

Shares of Concord Drugs Ltd was last trading in BSE at Rs. 85.97 as compared to the previous close of Rs. 83.11. The total number of shares traded during the day was 64645 in over 178 trades.

The stock hit an intraday high of Rs. 86.40 and intraday low of 80.32. The net turnover during the day was Rs. 5550988.00.

Source : Fortis Securities

Keywords

ConcordDrugs INE858L01010 Pharmaceuticals OrderWin